A carregar...
Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes
It has been clearly shown that iron overload adds progressively significant morbidity and mortality in patients with non-transfusion-dependent thalassemia (NTDT). The lack of physiological mechanisms to eliminate the excess of iron requires effective iron chelation therapy. The reduced compliance to...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4687615/ https://ncbi.nlm.nih.gov/pubmed/26719673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S40694 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|